Study of Copper Metallodrugs as Potential Inhibitor of Cancer via Molecular Docking and DFT
Cancer remains a leading cause of mortality worldwide, demanding the development of novel therapeutic strategies. Recent advances in molecular biology and pharmacology have facilitated the discovery of new agents with potential anti-cancer activity. This study aims to elucidate the mechanisms under...
Saved in:
| Main Authors: | Gopala Krishna Murthy H R, Revanasiddappa H.D., Ajay Kumar B, Prema M, Mahendra M, Keshav Kumar H, Vasantha Kumar BC, Sanjeevrayappa C |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Federal de Mato Grosso do Sul
2025-05-01
|
| Series: | Orbital: The Electronic Journal of Chemistry |
| Subjects: | |
| Online Access: | https://periodicos.ufms.br/index.php/orbital/article/view/22206 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rhodium-based metallodrugs for biological applications: current status and future perspectives
by: Wang Xiang, et al.
Published: (2025-08-01) -
Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights
by: Wei Chen, et al.
Published: (2025-07-01) -
Bispecific antibody for lung cancer: mechanisms and clinical insights
by: Wei Chen, et al.
Published: (2025-05-01) -
Novel therapies for high-grade gliomas: A vision for future
by: Vivek Tandon, et al.
Published: (2012-01-01) -
Combining Experimental and Computational Tools to Unravel Copper-Based Metallodrug Interactions With Proteins
by: Quim Peña, et al.
Published: (2025-01-01)